Accueil   Diary - News   All news iDD biotech enters worldwide exclusive licence

iDD biotech enters worldwide exclusive licence

iDD biotech enters worldwide exclusive licence concerning antibodies and patents related to CK8

 

iDD biotech has announced earlier today the signature of an exclusive worldwide licence with PULSALYS, the Technology Transfer Office of Lyon University, to scale-up and accelerate the development of iDD005 R&D project targeting CK8.


Read the press release